Dmitriy Zamarin

TOX is a critical regulator of tumour-specific T cell differentiation

Andrew Scott, Friederike Dündar, Paul Zumbo et al. · Nature · 2019 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +14

Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy

Dmitriy Zamarin, Rikke Holmgaard, Sumit K. Subudhi et al. · Science Translational Medicine · 2014 · 704 citations

Medicine, Immunology, Oncology +17

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Bastien Nguyen, Christopher J. Fong, Anisha Luthra et al. · Cell · 2022 · 646 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

Rikke Holmgaard, Dmitriy Zamarin, David H. Munn et al. · The Journal of Experimental Medicine · 2013 · 636 citations · Full text

Medicine, Oncology, Pharmacology +17

A Single Mutation in the PB1-F2 of H5N1 (HK/97) and 1918 Influenza A Viruses Contributes to Increased Virulence

Gina M. Conenello, Dmitriy Zamarin, Lucy A. Perrone et al. · PLoS Pathogens · 2007 · 523 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16